Plasmin modulates the thrombin-evoked calcium response in C6 glioma cells
- PMID: 8280096
- PMCID: PMC1137807
- DOI: 10.1042/bj2970175
Plasmin modulates the thrombin-evoked calcium response in C6 glioma cells
Abstract
Extracellular proteinases may be selectively targeted to cell surfaces by specific receptors or binding sites. In previous studies, we have characterized cellular binding sites for plasminogen and plasmin on rat C6 glioma cells. In this investigation, we studied the response of C6 cells to alpha-thrombin and plasmin by measuring the rapid kinetics of free intracellular Ca2+ concentrations ([Ca2+]i). Thrombin produced a strong, concentration-dependent rise in [Ca2+]i with an onset within 3 s and peak levels achieved in less than 10 s. A similar response was also evoked by an SFLLRN-containing thrombin-agonist peptide. C6 cells did not respond to plasmin (25 nM-1.5 microM). By contrast, pretreatment of C6 cells with 100 nM plasmin significantly inhibited the [Ca2+]i response to thrombin and the thrombin-agonist peptide. The peak [Ca2+]i response to thrombin, in cells pretreated with plasmin, was reduced by approx. 50%. The effect of plasmin on the cellular response to thrombin was selective, as pretreatment of the cells with plasmin did not affect the [Ca2+]i response to platelet-activating factor. Di-isopropylphosphorylplasmin and plasminogen did not inhibit the cellular response to thrombin, indicating that plasmin activity is required and that occupancy of cellular plasmin(ogen)-binding sites alone is insufficient. These studies demonstrate that plasmin does not directly induce a response in C6 cells, but may affect cellular function by specifically modulating the thrombin response.
Similar articles
-
Lithium chloride inhibits thrombin-induced intracellular calcium mobilization in C6 rat glioma cells.Prog Neuropsychopharmacol Biol Psychiatry. 2000 Jan;24(1):85-95. doi: 10.1016/s0278-5846(99)00082-2. Prog Neuropsychopharmacol Biol Psychiatry. 2000. PMID: 10659985
-
Co-existence of two types of [Ca2+]i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells.Neuroscience. 1998 Sep;86(2):597-609. doi: 10.1016/s0306-4522(97)00686-6. Neuroscience. 1998. PMID: 9881872
-
Plasmin-platelet interaction involves cleavage of functional thrombin receptor.Am J Physiol. 1996 Jul;271(1 Pt 1):C54-60. doi: 10.1152/ajpcell.1996.271.1.C54. Am J Physiol. 1996. PMID: 8760030
-
Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.Biochemistry. 1999 Apr 6;38(14):4572-85. doi: 10.1021/bi9824792. Biochemistry. 1999. PMID: 10194379
-
High and moderate affinity pathways for alpha-thrombin-induced platelet activation.Proc Soc Exp Biol Med. 1991 Dec;198(3):792-9. doi: 10.3181/00379727-198-43321d. Proc Soc Exp Biol Med. 1991. PMID: 1658806 Review. No abstract available.
Cited by
-
Tissue-type plasminogen activator neutralizes LPS but not protease-activated receptor-mediated inflammatory responses to plasmin.J Leukoc Biol. 2019 Apr;105(4):729-740. doi: 10.1002/JLB.3A0818-329RRR. Epub 2019 Jan 28. J Leukoc Biol. 2019. PMID: 30690783 Free PMC article.
-
Thrombin has a bimodal effect on glioma cell growth.Br J Cancer. 1997;76(12):1592-5. doi: 10.1038/bjc.1997.602. Br J Cancer. 1997. PMID: 9413947 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous